Pharmacyclics Switzerland GmbH
Clinical trials sponsored by Pharmacyclics Switzerland GmbH, explained in plain language.
Now part of
AbbVie Inc.
ABBV
NYSE
Subsidiary of AbbVie, involved in oncology drug development.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Lifeline for blood cancer patients: extended access to promising drug Results expected May 2027 (estimated)